Eylea injection treatment is the most effective treatment option available for correcting macular edema in a number of eye disorders.
It is an anti-VEGF (vascular endothelial growth factor) medication that works by blocking the growth of new abnormal blood vessels.
Eylea injection treatment is the most common treatment option for:
Eylea injection treatment is required to ensure a higher quality of life for the patient.
As the macular edema progresses, the patient can experience altered vision including
If the treatment is not provided, the associated growth of new blood vessels in the eye and edema can result in scarring and loss of central vision.
Eylea injection treatment is suitable for any individual who is:
Eylea injection treatment is an outpatient procedure.
In order to prepare for the treatment, the patient should be adequately counselled to ensure that the informed consent obtained is fully understood.
The patient is also advised to not wear any makeup for the treatment.
It simply involves:
The injection is initially given monthly, followed by a single injection every two months.
After a year of treatment, the doctor will reevaluate the patient and determine how the treatment should be continued.
The doctor will advise the patient to rest in his office after the procedure and provide refreshments. The doctor will then check the eyes of the patient under a microscope before discharging them.
The patients are not allowed to drive immediately after the operation and should make alternative arrangements for transport.
The patient will also be prescribed antibiotic and anti-inflammatory eye drops they should use as instructed.
Patients will experience blurry vision for up to 24 hours, but this varies from case to case. Visual recovery is very quick after the procedure.
Eylea injection treatment carries the same risk as any eye treatment, which includes
In rarer cases, Eylea treatment can result in infection and even retinal detachment.